{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:24:22Z","timestamp":1793967862770,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":230,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272433"],"award-info":[{"award-number":["82272433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203797"],"award-info":[{"award-number":["82203797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.101112","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T11:42:42Z","timestamp":1788694962000},"page":"101112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A serum Golgi Protein 73 (GP73)-based model for evaluating inflammation associated with drug-induced liver injury"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3700-9891","authenticated-orcid":false,"given":"Yamei","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5341-1714","authenticated-orcid":false,"given":"Mingjie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1811-042X","authenticated-orcid":false,"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-5677","authenticated-orcid":false,"given":"Shuhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-8885","authenticated-orcid":false,"given":"Danli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6136-5875","authenticated-orcid":false,"given":"Ziyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3827-4965","authenticated-orcid":false,"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4345-2149","authenticated-orcid":false,"given":"Jingmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1832-3209","authenticated-orcid":false,"given":"Fengmin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinsp.2026.101112_bib0001","first-page":"341","article-title":"Guidelines for the diagnosis and treatment of drug-induced liver injury in China (2023 edition)","volume":"27","author":"Ma","year":"2022","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101112_bib0002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12072-017-9793-2","article-title":"CSH guidelines for the diagnosis and treatment of drug-induced liver injury","volume":"11","author":"Yu","year":"2017","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101112_bib0003","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical Practice Guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.clinsp.2026.101112_bib0004","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101112_bib0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","article-title":"Drug-induced liver injury: asia Pacific Association of Study of Liver consensus guidelines","volume":"15","author":"Devarbhavi","year":"2021","journal-title":"Hepatol Int"},{"issue":"9","key":"10.1016\/j.clinsp.2026.101112_bib0006","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/liv.15262","article-title":"Incidence and risk factors of drug-induced liver injury","volume":"42","author":"Li","year":"2022","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.clinsp.2026.101112_bib0007","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in mainland China","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101112_bib0008","first-page":"80","article-title":"Traditional Chinese medicine induced liver injury","volume":"2","author":"Teschke","year":"2014","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101112_bib0009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.14218\/JCTH.2017.00033","article-title":"Traditional Chinese medicine and herb-induced liver injury: comparison with drug-induced liver injury","volume":"6","author":"Jing","year":"2018","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101112_bib0010","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jhep.2018.05.013","article-title":"Pharmacogenomics of drug-induced liver injury (DILI): molecular biology to clinical applications","volume":"69","author":"Kaliyaperumal","year":"2018","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.clinsp.2026.101112_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021836","article-title":"Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China","volume":"6","author":"Shang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clinsp.2026.101112_bib0012","first-page":"347","article-title":"Study on the assessment of liver fibrosis in chronic hepatitis B using virtual elastography","volume":"32","author":"Wang","year":"2023","journal-title":"J Imaging Diagn Interv Radiol"},{"issue":"1\u20132","key":"10.1016\/j.clinsp.2026.101112_bib0013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-1119(00)00136-0","article-title":"GP73, a novel Golgi-localized protein upregulated by viral infection","volume":"249","author":"Kladney","year":"2000","journal-title":"Gene"},{"issue":"12","key":"10.1016\/j.clinsp.2026.101112_bib0014","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/gut.2010.214916","article-title":"Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma","volume":"59","author":"Mao","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.clinsp.2026.101112_bib0015","first-page":"689","article-title":"Changes in serum GP73 and miR-27a levels in breast cancer patients and their correlation with clinical pathology and chemotherapy efficacy","volume":"35","author":"Lu","year":"2024","journal-title":"Hainan Med J"},{"key":"10.1016\/j.clinsp.2026.101112_bib0016","first-page":"87","article-title":"Expression levels of GP73 and miR-218-5p in human colorectal cancer and their relationship with clinical pathological features and prognosis of patients","volume":"24","author":"Ren","year":"2024","journal-title":"J Trop Med"},{"key":"10.1016\/j.clinsp.2026.101112_bib0017","first-page":"47","article-title":"Expression and clinical significance of golgi protein GP73 and ki-67 in gallbladder cancer","volume":"33","author":"Liu","year":"2017","journal-title":"J Pract Med"},{"issue":"16\u201317","key":"10.1016\/j.clinsp.2026.101112_bib0018","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clinbiochem.2014.08.010","article-title":"Serum GP73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection","volume":"47","author":"Qiao","year":"2014","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101112_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053862","article-title":"Serum GP73, a marker for evaluating progression in patients with chronic HBV infections","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.clinsp.2026.101112_bib0020","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.18632\/oncotarget.14954","article-title":"Serum golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clinsp.2026.101112_bib0021","first-page":"1262","article-title":"Serological diagnosis of hepatocellular carcinoma: challenges and hopes coexist","volume":"33","author":"Lu","year":"2017","journal-title":"J Clin Hepatobiliary Dis"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101112_bib0022","first-page":"321","article-title":"Diagnostic application of serum GP73 and the relevant mechanism in the diagnosis of liver cirrhosis","volume":"26","author":"Lu","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"12","key":"10.1016\/j.clinsp.2026.101112_bib0023","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000659","article-title":"Serum golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease","volume":"94","author":"Xu","year":"2015","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101112_bib0024","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41598-018-36480-3","article-title":"Serum GP73: an additional biochemical marker for liver inflammation in chronic HBV infected patients with normal or slightly raised ALT","volume":"9","author":"Wei","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinsp.2026.101112_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6036904","article-title":"Serum Golgi protein 73 as a potential biomarker for hepatic necroinflammation in population with nonalcoholic steatohepatitis","volume":"2020","author":"Wang","year":"2020","journal-title":"Dis Markers"},{"issue":"12","key":"10.1016\/j.clinsp.2026.101112_bib0026","article-title":"Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis","volume":"49","author":"Li","year":"2021","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clinsp.2026.101112_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4253566","article-title":"Diagnostic value of serum Golgi protein 73 for liver inflammation in patients with autoimmune hepatitis and primary biliary cholangitis","volume":"2022","author":"Yao","year":"2022","journal-title":"Dis Markers"},{"key":"10.1016\/j.clinsp.2026.101112_bib0028","first-page":"41","article-title":"The effect and mechanism of metformin on acute liver injury and inflammatory response induced by d-galactosamine combined with Pam3CSK4 in SD rats","volume":"39","author":"Wu","year":"2018","journal-title":"J Xi'an Jiaotong Univ Med Sci"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101112_bib0029","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S2468-1253(19)30344-9","article-title":"Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad","volume":"5","author":"Ghany","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinsp.2026.101112_bib0030","first-page":"136","article-title":"Investigation of the reference range of GP73 in healthy populations and its significance","volume":"30","author":"Chen","year":"2014","journal-title":"Pract Med J"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101112_bib0031","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34714-y","article-title":"Serum golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101112_bib0032","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/jmv.25045","article-title":"Predictive value of serum golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection","volume":"90","author":"Xu","year":"2018","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinsp.2026.101112_bib0033","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2019.02.019","article-title":"Serum GP73 combined AST and GGT reflects moderate to severe liver inflammation in chronic hepatitis B","volume":"493","author":"Yao","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.clinsp.2026.101112_bib0034","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/liv.13536","article-title":"Algorithm of golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection","volume":"37","author":"Cao","year":"2017","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"10.1016\/j.clinsp.2026.101112_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jvh.12786","article-title":"Assessment of serum golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection","volume":"24","author":"Cao","year":"2017","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101112_bib0036","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12016-017-8655-y","article-title":"The clinical significance of GP73 in immunologically mediated chronic liver diseases: experimental data and literature review","volume":"54","author":"Yao","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clinsp.2026.101112_bib0037","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3862024","article-title":"Exploring the diagnostic potential of serum Golgi protein 73 for hepatic necroinflammation and fibrosis in chronic HCV infection with different stages of liver injuries","volume":"2019","author":"Qian","year":"2019","journal-title":"Dis Markers"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101112_bib0038","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41419-020-2648-0","article-title":"Inhibition of miR-450b-5p ameliorates hepatic ischemia\/reperfusion injury via targeting CRYAB","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101112_bib0039","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s10020-023-00653-2","article-title":"TRIM37 exacerbates hepatic ischemia\/reperfusion injury by facilitating ikk\u03b3 translocation","volume":"29","author":"Yang","year":"2023","journal-title":"Mol Med"},{"key":"10.1016\/j.clinsp.2026.101112_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107928","article-title":"FBXW5 aggravates hepatic ischemia\/reperfusion injury via promoting phosphorylation of ASK1 in a TRAF6-dependent manner","volume":"99","author":"Li","year":"2021","journal-title":"Int Immunopharmacol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:24:48Z","timestamp":1793964288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593226002395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"alternative-id":["S1807593226002395"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101112","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A serum Golgi Protein 73 (GP73)-based model for evaluating inflammation associated with drug-induced liver injury","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101112"}}